
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
(Image credit: Visoot Uthairam/Moment RF)


All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
(Image credit: Visoot Uthairam/Moment RF)
Originally reported by NPR. Read the original article